Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study. Kleinschnitz C, Niemczyk G, Rehberg-Weber K, Wernsdörfer C Int J Mol Sci. 2015; 16(7):15271-86. PMID: 26154767. Abstract CommentRecommendBookmarkWatch